Hill's Pet Nutrition Reports Sales Growth in Q3 2026

The pet food brand generated $1.205 billion in net sales during the third quarter of 2026.

Updated on Oct. 30, 2026 in Pet Health

Hill's Pet Nutrition Reports Sales Growth in Q3 2026

Live Poll

Do you still prioritize buying premium name-brand products for your household despite higher retail prices?

Hill's Pet Nutrition recorded $1.205 billion in net sales during the third quarter of 2026, marking a 5.6% increase compared to the same period in 2025. This performance accounted for 22% of parent company Colgate-Palmolive's total quarterly revenue.

Why it matters

The steady growth across the company's Prescription Diet and Science Diet brands underscores the ongoing demand for therapeutic pet nutrition and veterinary-recommended products. This performance continues despite a deliberate exit from private-label production.

Organic sales for the quarter increased 5.7% after accounting for a 70 basis point decline caused by the company's departure from private-label operations. Operating profit for the division rose 5% to $267 million, resulting in an operating profit margin of 22.2%.

The players

Hill's Pet Nutrition

This American pet food manufacturer specializes in clinical nutrition products and is a subsidiary of Colgate-Palmolive.

Colgate-Palmolive

This multinational consumer products company owns a variety of brands and functions as the parent organization for Hill's Pet Nutrition.

The details

Growth during the quarter was driven by a 1.8% increase in volume and a 3.9% contribution from pricing strategies. The company also initiated a U.S. expansion into the fresh pet food category, leveraging technical experience gained through its earlier acquisition of Prime100.

Hill's recorded $1.142 billion in net sales during Q3 2025.
Hill's began a phased rollout of fresh dog food in July 2026.
The third quarter of 2026 saw Hill's reach $1.205 billion in net sales.
Colgate-Palmolive officially released the Q3 2026 earnings report on October 30, 2026.

Culture Shift

Hill's expansion into fresh categories aligns with the broader societal shift toward humanizing pet diets and prioritizing high-quality, whole-food ingredients. This strategy positions the company to compete directly against rising boutique fresh-food brands by leveraging established veterinary relationships.

Consumers may notice an increased variety of fresh food options in retail locations as the company completes its phased rollout across the United States. These additions to the product lineup reflect a shift in how pet owners can access fresh, science-backed nutrition in their local stores.

The takeaway

The company's focus on its core Prescription Diet and Science Diet lines proves that premium therapeutic products remain a resilient segment for pet owners. Consumers should watch for new fresh-food options hitting shelves as the brand diversifies its portfolio beyond traditional kibble.